Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models
暂无分享，去创建一个
M. Amiot | F. Peale | Leslie B. Lee | W. Fairbrother | J. Leverson | D. Sampath | P. Tapang | Peng Yue | M. Mitten | E. Punnoose | A. Souers | E. Boghaert | J. Oeh | L. Belmont | E. Ingalla | S. Maiga | Nguyen Tan | W. Darbonne | Anatol Oleksijew | Amy E. Young